Home > Resources > Articles > A Very Merry Month for Mental Health in Denver

A Very Merry Month for Mental Health in Denver

Earlier this month it was announced that the state of Colorado was awarded $65 million in State Innovation Model (SIM) funding to create a coordinated, accountable system of care that gives Coloradans access to integrated primary care and behavioral health. This award came on the heels of the news that the city of Denver would become the first and only metropolitan area to establish an Office of Behavioral Strategies to coordinate behavioral health efforts amongst several city departments that have mental health components.

Spotlight

AMC - Academic Medical Center

The Academic Medical Center, or AMC in short, operates as one of the eight university medical center in the Netherlands. It offers health care, education and research. The company’s health care services include referral care, clinical care and general specialist care in the areas of cardiovascular disease, clinical genetics, pediatrics, microsurgery, dermatology, human reproduction, oncology, endocrinology, virology, immunology, liver disease, ophthalmology, neurology, neurosurgery, psychiatry and public health.

OTHER ARTICLES
Healthtech Security

Medical Computers: A Necessity of the Future Healthcare

Article | November 29, 2023

Over the last couple of years, the healthcare industry has witnessed significant technological advancements transforming numerous procedures and treatments, ranging from magnetic resonance imaging scanners and radiotherapy to antibiotics and anesthetics. In addition, the introduction of novel technologies (new pharmaceuticals and treatments, new equipment, new social media support for healthcare, etc.) has further provided air to the fire for innovation in the sector, encouraging healthcare providers to upgrade their technological infrastructure. Medical Computers Paving the Way in Healthcare Use of modern technology, such as medical computers, is becoming more and more crucial in healthcare institutions, including hospitals, clinics, and specialized treatment centers. These computers are used in hospitals for a variety of purposes, from better laparoscopic, minimally invasive surgical techniques used by surgeons to patient tracking and health monitoring gadgets. Medical computers are becoming more prevalent as they help medical professionals make faster, more reliable, and more accurate decisions. Additionally, they enable the emergence of new data, integrate advanced technologies such as artificial intelligence, and enhance decision-making processes, which are particularly crucial when it comes to medical diagnostics and treatment. New computer and technology solutions in the healthcare sector are enabling a wide range of outcomes that were previously unimaginable. They assist medical practitioners in both data collection and data interpretation, enabling them to make decisions that are thoroughly informed by insight. Here are some of the applications that have experienced immense transformation in recent years Hospital Information Systems Medical Personnel and Staff Management Data Analysis in Medicine Medical Imaging Computer-assisted Therapy Laboratory Computing Critical Patient Care Computer Assisted Decision-making (CMD) Patient Check-In and Status Growing Adoption Encouraging Product Launches With technologies like medical computers becoming essential for processing numerous day-to-day operations in the healthcare industry, the need for these computers is growing at a rapid pace. Hence, a number of medical equipment providers are emphasizing on offering cutting-edge solutions to modern healthcare facilities. For instance, in 2021, American Portwell Technology, Inc., a world-leading innovator of the Industrial PC, unveiled two certification-ready all-in-one medical computers - MEDS-P2410-P200 (23.8″) and MEDS-P2210-P200 (21.5″) with features such as true-flat capacitive touchscreen and optional hot-swappable batteries.

Read More
Health Technology

How Virtual Care and Telehealth are Redefining Healthcare

Article | September 12, 2023

Virtual care and telehealth are no longer seen as merely an innovative method of delivering healthcare; technology is now indispensable to protecting patients, staff, and PPE resources amid the coronavirus pandemic. In a recent Harvard Medical School blog, Lee H. Schwamm, MD, shared that “telehealth, the virtual care platforms that allow health care professionals and patients to meet by phone or video chat, seems tailor-made for this moment in time… The current crisis makes virtual care solutions like telehealth an indispensable tool.” He believes that the role of telehealth is vital to our country as “it can help flatten the curve of infections and help us to deploy medical staff and lifesaving equipment wisely.”

Read More
Digital Healthcare

How AI is levelling the playing field when it comes to gender and healthcare

Article | November 29, 2023

Global efforts to tackle gender inequality have grown in recent years. But there is still so much to be done. Figures from the United Nations show that outcomes for women and girls continue to lag across a range of issues, including poverty, education, work and health. And according to the World Economic Forum, at the current rate, it will take 108 years to close the gender gap. Although healthcare is founded in objectivity and science, gender bias is still remarkably common. We wanted to understand more about female perceptions of healthcare, so we undertook consumer research that delved into the experiences of women compared to men. The results pointed to a clear disparity, finding that women are less likely to visit the doctor when they have symptoms of ill health and, in some cases, are taken less seriously when they do seek medical advice. Women being left behind According to our research, a significant proportion of British women feel disappointed in the healthcare they receive, with one in five reporting they weren’t taken seriously when presenting symptoms to a healthcare provider. What’s more, a staggering one in four said they are reluctant to seek medical advice at all for fear of wasting a GP’s time. These statistics suggest that, not only are female experiences of healthcare damaging their relationship with clinicians, but they could be eroding confidence in recognising and acting on warning signs and symptoms too. This sentiment is particularly evident when focusing on cardiac care. One in eight women (13%) feel ignored when presenting symptoms of heart disease to healthcare professionals, compared to just 4% of men. And of UK adults who have received a coronary heart disease (CHD) diagnosis, women experiencing symptoms were 55% more likely than men to visit the doctor multiple times before receiving a referral for further investigation. On top of this, women are five times more likely to receive a false finding from the cardiac stress tests that are traditionally used to assess heart health. “There does appear to be a gender bias in onward referral to secondary care and for diagnostics in the local area, which is influenced by the attending healthcare professionals’ risk assessment. Traditional teaching has led to gender bias, as we are programmed to attribute a lower level of pre-test probability and risk to females. This may have contributed to a general lack of awareness around cardiovascular health in women. For example, in a survey I carried out among more than 600 female employees working within North West Anglia NHS Foundation Trust, 82% said they didn’t feel informed about their cardiovascular health. Considering participants included some of the most medically informed women in the UK, the results speak volumes about how we view cardiac health among women.” - Dr Rebecca Schofield, consultant cardiologist at North West Anglia NHS Foundation Trust These widespread misconceptions around heart disease and heart attacks are often exacerbated by what we see in the media – think of the countless TV stereotypes of male characters clutching their chests and falling to the floor. But given that CHD is responsible for one in 13 female deaths, it appears that public health efforts have failed to make people aware of the risks for women. It is, perhaps, not surprising then that 42% of women with CHD did not immediately recognise their symptoms as signs of heart disease. In short, women are missing out on time-critical diagnoses and treatment due to a lack of awareness and education among both healthcare providers and the public. Technologies making a difference Thankfully, progress is being made to improve healthcare outcomes for women. Innovative technologies are increasingly providing diagnostic solutions that can reduce incidences of human bias and give clinicians greater clarity on the presence or severity of different conditions in their female patients. For example, AI is already being used to detect diseases such as cancer more accurately. Its adoption is facilitating reviews and translations of mammograms 30 times faster, with 99% accuracy, reducing the need for unnecessary biopsies. There’s extraordinary potential for AI and healthcare, and it’s something the NHS continues to recognise, most recently with the launch of its Artificial Intelligence Laboratory (AI Lab) and NHS England’s (NHSE) MedTech Funding Mandate. The latter aims to accelerate the uptake of selected innovative medical devices, diagnostics, and digital products to patients. As part of the NHS efforts, NHSE has mandated the HeartFlow Analysis for use in hospitals across England for patients, male or female, who might otherwise be sent for a cardiac stress test. The HeartFlow Analysis is a gender-neutral technology that takes data from a coronary CT scan of the heart and leverages deep learning (a form of AI) and highly trained analysts to create a personalised, digital 3D model of each patient’s coronary arteries. This then helps clinicians to quickly diagnose CHD and decide the appropriate treatment for patients of any gender. Time spent in hospital is minimised for patients and often layered testing and unnecessary invasive diagnostic procedures can be avoided. Final thoughts While AI is helping us tackle gender bias in certain areas such as oncologic and cardiac testing, healthcare professionals are not absolved of responsibility when it comes to confronting this problem. It remains incumbent upon clinicians to recognise unconscious bias that would deter them from referring women or minority patients for much-needed testing. Outside of the hospital, public health education efforts must expand so that far more of us can recognise shortness of breath, nausea, vomiting, back or jaw pain, and other symptoms beyond chest pain to be indicators of a heart attack in a woman. Knowing what to look for and overcoming personal bias that might lead to these signs being disregarded, may allow us to help one of the more than 100 women who will experience a heart attack in the UK today.

Read More
Healthcare Analytics

Importance of Mental Health for Sustainable Development

Article | May 11, 2022

Mental illness is a fatal illness. Surprisingly, mental health is grossly underfunded all over the world. Despite countries' economic strength, there are still no long-term and solution-driven results for addressing mental health. According to WHO reports, only one in every fifty people receives medical treatment for severe mental illnesses. The Sustainable Development Goals (SDGs) are a global initiative to create a more equitable and sustainable world. According to the World Health Organization, "there can be no health or sustainable development without proper mental health." As a result, mental health is one of the most critical pillars in creating a sustainable world in the future. In short, if mental health is good, sustainability will follow naturally. Positive Mental Health = Thriving Sustainability According to the WHO’s decision-making body, ‘The World Health Assembly (WHA),’ mental health deserves to be at the top of the sustainability agenda because it affects people of all ages. It means anybody can be diagnosed with a mental illness, which is directly proportionate to sustainable development. So, a similar amount of treatments, diagnoses, and awareness should help people overcome mental illness. However, on the other hand, according to the WHO's 2020 Mental Health Atlas, only 23% of patients with mental illnesses have been integrated into healthcare systems in developing countries. This highlights the undeniable fact that the world's 280 million people suffering from depression have been kept away from receiving a proper diagnosis, treatment, and care. Moreover, up to 85% of people with mental illnesses are untreated. The numbers are shocking! Such statistics are enough evidence to create a supportive culture free of the stigma that mental illness is incurable and encourage patients to seek help when they need it. It includes geography-specific mental health resources, proper diagnosis, care, medication, availability, accessibility, other requirements, and adequate support systems. Global Action is Key to Both Providers of mental health services cannot do it alone. Instead, it requires a strong global response. In this case, leading companies and legislative bodies should exert influence to promote cost-effective, widely accessible, and evidence-based treatments for mental health disorders. Some low-cost solutions to this global problem will eradicate it and bring about long-term development to support this point. As a result, the solutions are as follows Improving social and economic environments as part of sustainable development Integrating mental health into general primary health care Providing appropriate care and treatment through trained and supervised community members Using technology to introduce the most up-to-date solutions for mental health disorders Wrapping Up Transformation is essential today, both technically and in terms of humanizing. Otherwise, sustainable development will be impossible to achieve unless the enormous challenge of mental health is addressed. Therefore, healthcare leaders will need to develop transitional plans to increase coverage in real-time to accomplish this. This should include proper diagnosis and progressive tracking of mental health treatments.

Read More
Healthtech Security

NIS2 Cybersecurity Rules are Coming: Are You Ready?

Article | November 29, 2023

Over the last couple of years, the healthcare industry has witnessed significant technological advancements transforming numerous procedures and treatments, ranging from magnetic resonance imaging scanners and radiotherapy to antibiotics and anesthetics. In addition, the introduction of novel technologies (new pharmaceuticals and treatments, new equipment, new social media support for healthcare, etc.) has further provided air to the fire for innovation in the sector, encouraging healthcare providers to upgrade their technological infrastructure. Medical Computers Paving the Way in Healthcare Use of modern technology, such as medical computers, is becoming more and more crucial in healthcare institutions, including hospitals, clinics, and specialized treatment centers. These computers are used in hospitals for a variety of purposes, from better laparoscopic, minimally invasive surgical techniques used by surgeons to patient tracking and health monitoring gadgets. Medical computers are becoming more prevalent as they help medical professionals make faster, more reliable, and more accurate decisions. Additionally, they enable the emergence of new data, integrate advanced technologies such as artificial intelligence, and enhance decision-making processes, which are particularly crucial when it comes to medical diagnostics and treatment. New computer and technology solutions in the healthcare sector are enabling a wide range of outcomes that were previously unimaginable. They assist medical practitioners in both data collection and data interpretation, enabling them to make decisions that are thoroughly informed by insight. Here are some of the applications that have experienced immense transformation in recent years Hospital Information Systems Medical Personnel and Staff Management Data Analysis in Medicine Medical Imaging Computer-assisted Therapy Laboratory Computing Critical Patient Care Computer Assisted Decision-making (CMD) Patient Check-In and Status Growing Adoption Encouraging Product Launches With technologies like medical computers becoming essential for processing numerous day-to-day operations in the healthcare industry, the need for these computers is growing at a rapid pace. Hence, a number of medical equipment providers are emphasizing on offering cutting-edge solutions to modern healthcare facilities. For instance, in 2021, American Portwell Technology, Inc., a world-leading innovator of the Industrial PC, unveiled two certification-ready all-in-one medical computers - MEDS-P2410-P200 (23.8″) and MEDS-P2210-P200 (21.5″) with features such as true-flat capacitive touchscreen and optional hot-swappable batteries.

Read More
Health Technology

5 Ways AI is Likely to Benefit Medicine & Improve Patient Care

Article | September 12, 2023

Virtual care and telehealth are no longer seen as merely an innovative method of delivering healthcare; technology is now indispensable to protecting patients, staff, and PPE resources amid the coronavirus pandemic. In a recent Harvard Medical School blog, Lee H. Schwamm, MD, shared that “telehealth, the virtual care platforms that allow health care professionals and patients to meet by phone or video chat, seems tailor-made for this moment in time… The current crisis makes virtual care solutions like telehealth an indispensable tool.” He believes that the role of telehealth is vital to our country as “it can help flatten the curve of infections and help us to deploy medical staff and lifesaving equipment wisely.”

Read More
Digital Healthcare

The Key Ingredient in Healthcare Compliance Success

Article | November 29, 2023

Global efforts to tackle gender inequality have grown in recent years. But there is still so much to be done. Figures from the United Nations show that outcomes for women and girls continue to lag across a range of issues, including poverty, education, work and health. And according to the World Economic Forum, at the current rate, it will take 108 years to close the gender gap. Although healthcare is founded in objectivity and science, gender bias is still remarkably common. We wanted to understand more about female perceptions of healthcare, so we undertook consumer research that delved into the experiences of women compared to men. The results pointed to a clear disparity, finding that women are less likely to visit the doctor when they have symptoms of ill health and, in some cases, are taken less seriously when they do seek medical advice. Women being left behind According to our research, a significant proportion of British women feel disappointed in the healthcare they receive, with one in five reporting they weren’t taken seriously when presenting symptoms to a healthcare provider. What’s more, a staggering one in four said they are reluctant to seek medical advice at all for fear of wasting a GP’s time. These statistics suggest that, not only are female experiences of healthcare damaging their relationship with clinicians, but they could be eroding confidence in recognising and acting on warning signs and symptoms too. This sentiment is particularly evident when focusing on cardiac care. One in eight women (13%) feel ignored when presenting symptoms of heart disease to healthcare professionals, compared to just 4% of men. And of UK adults who have received a coronary heart disease (CHD) diagnosis, women experiencing symptoms were 55% more likely than men to visit the doctor multiple times before receiving a referral for further investigation. On top of this, women are five times more likely to receive a false finding from the cardiac stress tests that are traditionally used to assess heart health. “There does appear to be a gender bias in onward referral to secondary care and for diagnostics in the local area, which is influenced by the attending healthcare professionals’ risk assessment. Traditional teaching has led to gender bias, as we are programmed to attribute a lower level of pre-test probability and risk to females. This may have contributed to a general lack of awareness around cardiovascular health in women. For example, in a survey I carried out among more than 600 female employees working within North West Anglia NHS Foundation Trust, 82% said they didn’t feel informed about their cardiovascular health. Considering participants included some of the most medically informed women in the UK, the results speak volumes about how we view cardiac health among women.” - Dr Rebecca Schofield, consultant cardiologist at North West Anglia NHS Foundation Trust These widespread misconceptions around heart disease and heart attacks are often exacerbated by what we see in the media – think of the countless TV stereotypes of male characters clutching their chests and falling to the floor. But given that CHD is responsible for one in 13 female deaths, it appears that public health efforts have failed to make people aware of the risks for women. It is, perhaps, not surprising then that 42% of women with CHD did not immediately recognise their symptoms as signs of heart disease. In short, women are missing out on time-critical diagnoses and treatment due to a lack of awareness and education among both healthcare providers and the public. Technologies making a difference Thankfully, progress is being made to improve healthcare outcomes for women. Innovative technologies are increasingly providing diagnostic solutions that can reduce incidences of human bias and give clinicians greater clarity on the presence or severity of different conditions in their female patients. For example, AI is already being used to detect diseases such as cancer more accurately. Its adoption is facilitating reviews and translations of mammograms 30 times faster, with 99% accuracy, reducing the need for unnecessary biopsies. There’s extraordinary potential for AI and healthcare, and it’s something the NHS continues to recognise, most recently with the launch of its Artificial Intelligence Laboratory (AI Lab) and NHS England’s (NHSE) MedTech Funding Mandate. The latter aims to accelerate the uptake of selected innovative medical devices, diagnostics, and digital products to patients. As part of the NHS efforts, NHSE has mandated the HeartFlow Analysis for use in hospitals across England for patients, male or female, who might otherwise be sent for a cardiac stress test. The HeartFlow Analysis is a gender-neutral technology that takes data from a coronary CT scan of the heart and leverages deep learning (a form of AI) and highly trained analysts to create a personalised, digital 3D model of each patient’s coronary arteries. This then helps clinicians to quickly diagnose CHD and decide the appropriate treatment for patients of any gender. Time spent in hospital is minimised for patients and often layered testing and unnecessary invasive diagnostic procedures can be avoided. Final thoughts While AI is helping us tackle gender bias in certain areas such as oncologic and cardiac testing, healthcare professionals are not absolved of responsibility when it comes to confronting this problem. It remains incumbent upon clinicians to recognise unconscious bias that would deter them from referring women or minority patients for much-needed testing. Outside of the hospital, public health education efforts must expand so that far more of us can recognise shortness of breath, nausea, vomiting, back or jaw pain, and other symptoms beyond chest pain to be indicators of a heart attack in a woman. Knowing what to look for and overcoming personal bias that might lead to these signs being disregarded, may allow us to help one of the more than 100 women who will experience a heart attack in the UK today.

Read More
Healthcare Analytics

Importance of Mental Health for Sustainable Development

Article | May 11, 2022

Mental illness is a fatal illness. Surprisingly, mental health is grossly underfunded all over the world. Despite countries' economic strength, there are still no long-term and solution-driven results for addressing mental health. According to WHO reports, only one in every fifty people receives medical treatment for severe mental illnesses. The Sustainable Development Goals (SDGs) are a global initiative to create a more equitable and sustainable world. According to the World Health Organization, "there can be no health or sustainable development without proper mental health." As a result, mental health is one of the most critical pillars in creating a sustainable world in the future. In short, if mental health is good, sustainability will follow naturally. Positive Mental Health = Thriving Sustainability According to the WHO’s decision-making body, ‘The World Health Assembly (WHA),’ mental health deserves to be at the top of the sustainability agenda because it affects people of all ages. It means anybody can be diagnosed with a mental illness, which is directly proportionate to sustainable development. So, a similar amount of treatments, diagnoses, and awareness should help people overcome mental illness. However, on the other hand, according to the WHO's 2020 Mental Health Atlas, only 23% of patients with mental illnesses have been integrated into healthcare systems in developing countries. This highlights the undeniable fact that the world's 280 million people suffering from depression have been kept away from receiving a proper diagnosis, treatment, and care. Moreover, up to 85% of people with mental illnesses are untreated. The numbers are shocking! Such statistics are enough evidence to create a supportive culture free of the stigma that mental illness is incurable and encourage patients to seek help when they need it. It includes geography-specific mental health resources, proper diagnosis, care, medication, availability, accessibility, other requirements, and adequate support systems. Global Action is Key to Both Providers of mental health services cannot do it alone. Instead, it requires a strong global response. In this case, leading companies and legislative bodies should exert influence to promote cost-effective, widely accessible, and evidence-based treatments for mental health disorders. Some low-cost solutions to this global problem will eradicate it and bring about long-term development to support this point. As a result, the solutions are as follows Improving social and economic environments as part of sustainable development Integrating mental health into general primary health care Providing appropriate care and treatment through trained and supervised community members Using technology to introduce the most up-to-date solutions for mental health disorders Wrapping Up Transformation is essential today, both technically and in terms of humanizing. Otherwise, sustainable development will be impossible to achieve unless the enormous challenge of mental health is addressed. Therefore, healthcare leaders will need to develop transitional plans to increase coverage in real-time to accomplish this. This should include proper diagnosis and progressive tracking of mental health treatments.

Read More
MORE ARTICLES

Spotlight

AMC - Academic Medical Center

The Academic Medical Center, or AMC in short, operates as one of the eight university medical center in the Netherlands. It offers health care, education and research. The company’s health care services include referral care, clinical care and general specialist care in the areas of cardiovascular disease, clinical genetics, pediatrics, microsurgery, dermatology, human reproduction, oncology, endocrinology, virology, immunology, liver disease, ophthalmology, neurology, neurosurgery, psychiatry and public health.

Related News

Future of Healthcare

BioIntelliSense Joins Polaris Dawn Mission to Advance Understanding of Human Health in Space

BIOINTELLISENSE | November 15, 2022

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its partnership with the Translational Research Institute for Space Health (TRISH) to further understanding of human health in space. The BioButton® medical grade wearable device will be used for commercial spaceflight research programs and notably during the upcoming five-day Polaris Dawn mission. This historic mission will be flown by SpaceX and is scheduled to launch after March 2023. Medical and scientific research on human health in space promotes the advancement of translational technologies by adapting known technology for space applications, and by using space-based insights to improve healthcare at home. “BioIntelliSense has proudly gained industry recognition for its innovative and comprehensive portfolio of continuous multi-parameter monitoring solutions for application in the acute care environment, at home settings and now, in the next frontier of space, As a lifelong space exploration enthusiast, it is a tremendous honor to be working with TRISH on health research that can benefit astronauts and crews during commercial space flight and for the BioButton devices to be part of the upcoming Polaris Dawn mission.” -James Mault, MD, founder and CEO of BioIntelliSense The BioButton multi-parameter device is designed to be worn on the upper left chest and will passively capture trending physiologic and movement data from the Polaris Dawn crew during its milestone mission. The future of healthcare is here. Today, the BioIntelliSense Data-as-a-Service (DaaS) platform and clinical intelligence solution is commercially available and rapidly adopted by acute and post-acute providers in the U.S. along with select international markets. TRISH is proud to partner with innovative healthcare technology leaders like BioIntelliSense as we further our understanding of human health in space, Our EXPAND (Enhancing eXploration and ANalog Definition) commercial spaceflight health research platform provides unique opportunities to rapidly test technologies in orbit, as well as collect new datapoints on the health impact of spaceflight for a wider, more diverse population,said James Hury, TRISH Chief Innovation Officer and Deputy Director. BioIntelliSense (Booth #5025) and TRISH (Space Health Pavilion #2636) will be showcasing the BioButton wearable device and clinical intelligence solution at the premier HLTH 2022 conference November 13 – 16 in Las Vegas, NV. ABOUT BIOINTELLISENSE BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for remote patient monitoring (RPM). Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical grade remote care from in-hospital to home. ABOUT TRANSLATIONAL RESEARCH INSTITUTE for SPACE HEALTH (TRISH) Led by Baylor College of Medicine’s Center for Space Medicine, TRISH is a consortium that includes partners Caltech and MIT. NASA recently awarded the Institute a six-year extension to further its work by delivering disruptive solutions to mitigate biomedical risks for human exploration while advancing terrestrial health technologies.

Read More

Digital Healthcare

MedX Health and Health Partners Announce Agreement to Launch MedX’s Teledermatology Screening Platform

MedX Health Corp | March 03, 2022

MedX Health Corp.("MedX" or the "Company"), a global leader in teledermatology, is pleased to announce a Memorandum of Understanding (“MOU”) and the launch of a new commercialization pilot project with Health Partners (OH) Limited, a well-respected, privately-owned corporate health, treatment and primary care services company in the United Kingdom. Serving a broad client base comprising corporates, government agencies, insurers, health trusts, pension funds and individuals, Health Partners (“HP”) employs 700+ people with telehealth, mobile and on-site operations across the UK and the Republic of Ireland. The pilot will span three to six months and involve an estimated 600 patients across two of HP’s sites. Upon the successful completion of the pilot, the MedX DermSecure® Screening Platform will be made available to Health Partners' two million-plus patients. The agreement is the latest initiative in MedX’s global commercialization strategy and follows pilots recently launched across the Europe and Middle East region. "Health Partners’ Clinical Team constantly strives to identify leading technological innovations that offer the highest level of support to our two million-plus patients. MedX's leading skin assessment technology allows dermatologists to not only make more accurate diagnoses of pigmented lesions and moles, but to do that remotely and quickly. We are very proud to be partnering with MedX Health to bring this innovative and life-changing service to our clients.” Health Partners Managing Director Andrew Noble In addition to expanding its DermSecure® Screening Platform network globally, MedX has focused on building a presence in multiple market verticals such as pharmacies, medical clinics, building hubs, medical scanning clinics, mobile and remote medical practices, as well as esthetics and skincare clinics. The partnership with Health Partners represents MedX’s expansion into a new vertical; occupational health and wellbeing services. MedX Managing Director, Europe, Middle East and Africa (EMEA), Naman Demaghlatrous, added, "MedX is pleased to have established a presence in the strategic occupational health vertical. Health Partners brings our technology to a population of more than two million workers across the United Kingdom, thus expanding our footprint in the EMEA region considerably. We continue to execute on our strategy to identify strategic partnerships in the region that will allow us to grow our business and save lives simultaneously.” Health Partners will pilot MedX’s high-definition image-capture technology, SIAscopy®, and its secure, cloud-based patient management system, DermSecure®, which transmits and stores patient data throughout the assessment process. MedX's SIAscopy® is the only technology available that captures five high-resolution images of suspicious moles, lesions and skin conditions, including four spectrophotometric images taken 2mm below the skin's surface. This technology provides detailed patient scans, which a certified dermatologist can virtually assess within 72 hours. "We are honoured to be working with Health Partners on this most important initiative. According to Health & Safety Executive-commissioned research, there are more than 3000 cases of skin cancer annually in the construction industryalone. We are delighted to be entering the occupational health services market with a leader in the industry," stated Mike Druhan, MedX President, Dermatology Services. About Health Partners (OH) Ltd. Health Partners, headquartered in Uckfield, East Sussex, United Kingdom, is a leading health and wellbeing company, providing a full range of corporate health, treatment and primary care services to corporates, government, insurers, health trusts, pension funds and families. We combine expert advice and clinical services with smart systems to deliver impact-driven health programmes, tailored to improve people’s wellbeing and performance. Health Partners is founded on patient privacy and holds a significant number of accreditations, certifications and memberships, including ISO27001, CQC, SEQOHS and ISO9001. Health Partners offers its services across the United Kingdom and the Republic of Ireland, reaching two million plus people in organisations across several industries. About MedX Health Corp. MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view suspicious moles and lesions up to 2mm beneath in a pain-free, non-invasive manner. Its patented software then creates real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union, Brazil and Turkey.

Read More

Digital Healthcare

Cognizant Collaborates with Microsoft to Offer New Virtual Healthcare Solution for Remote Patient Monitoring and Improved Care

Cognizant | March 02, 2022

Cognizant today announced it is collaboratingwith Microsoft to delivera new digital health solution to enhance remote patient monitoring for improved medical care. Cognizant's new solution, leveraging components of the Microsoft Cloud for Healthcare, is the first of several planned offerings that combine remote patient monitoring and virtual health, utilizing products like smart watches, blood pressure monitors, and glucose meters to collect and communicate patient health data to providers. Built-in analytics allow providers to cross-reference historical health information to gain patient insights and potentially identify early warning signs of chronic conditions so preventative measures can be taken. Additionally, the solution's remote capabilities enable telehealth visits, which continue to be a valuable option to mitigate barriers of care for patients with accessibility constraints, as well as implement time-sensitive interventions and improve personalized care. With chronic diseases expected to account for 70% of global deaths by 2030, advancements in digital integration are quickly becoming recognized as an optimal approach to preventing, managing, and treating disease.* As an early Microsoft Cloud for Healthcare partner, Cognizant has designed a solution that leverages Microsoft Azure services including FHIR, API Services, and Teams integration to improve scalability and reliability. This digital healthcare endeavor is backed by Cognizant's dedicated Microsoft Business Group, bringing together Cognizant's digital modernization expertise with Microsoft's focus on building Industry Clouds to deliver a commercially available, comprehensive, healthcare solution. This new offering is the first in a series of digital healthcare solutions from Cognizant as the company accelerates its client offerings aimed at implementing advanced healthcare technology to increase patient engagement, enhance personalized care, provide remote patient monitoring, and facilitate improved patient outcomes. Future offerings will build upon existing solution capabilities to help clients expedite implementation. "The bridging of technology and healthcare is creating new opportunities to improve how providers monitor the health of their patients and engage with them for time-sensitive interventions. Utilizing data analytics, secure cloud technology and interoperability products, our collaboration with Microsoft offers a unique, scalable solution that aims to connect providers and patients, and enhances the quality, timeliness, and personalization of healthcare." Surya Gummadi, Head of Cognizant Healthcare "Cognizant's new virtual healthcare solution utilizes differentiated capabilities, built on the secure and compliant Microsoft Cloud, that make it easy for people to collect and share health data using their own devices, while ensuring that providers have the data and insights they need to diagnose and treat patients," saidTom McGuinness, Corporate Vice President, Global Healthcare and Life Sciences, Microsoft. "We look forward to combining our technologies and collective expertise to deliver additional solutions that offer high quality healthcare and enable patient well-being." About Cognizant Cognizantengineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life.

Read More

Future of Healthcare

BioIntelliSense Joins Polaris Dawn Mission to Advance Understanding of Human Health in Space

BIOINTELLISENSE | November 15, 2022

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its partnership with the Translational Research Institute for Space Health (TRISH) to further understanding of human health in space. The BioButton® medical grade wearable device will be used for commercial spaceflight research programs and notably during the upcoming five-day Polaris Dawn mission. This historic mission will be flown by SpaceX and is scheduled to launch after March 2023. Medical and scientific research on human health in space promotes the advancement of translational technologies by adapting known technology for space applications, and by using space-based insights to improve healthcare at home. “BioIntelliSense has proudly gained industry recognition for its innovative and comprehensive portfolio of continuous multi-parameter monitoring solutions for application in the acute care environment, at home settings and now, in the next frontier of space, As a lifelong space exploration enthusiast, it is a tremendous honor to be working with TRISH on health research that can benefit astronauts and crews during commercial space flight and for the BioButton devices to be part of the upcoming Polaris Dawn mission.” -James Mault, MD, founder and CEO of BioIntelliSense The BioButton multi-parameter device is designed to be worn on the upper left chest and will passively capture trending physiologic and movement data from the Polaris Dawn crew during its milestone mission. The future of healthcare is here. Today, the BioIntelliSense Data-as-a-Service (DaaS) platform and clinical intelligence solution is commercially available and rapidly adopted by acute and post-acute providers in the U.S. along with select international markets. TRISH is proud to partner with innovative healthcare technology leaders like BioIntelliSense as we further our understanding of human health in space, Our EXPAND (Enhancing eXploration and ANalog Definition) commercial spaceflight health research platform provides unique opportunities to rapidly test technologies in orbit, as well as collect new datapoints on the health impact of spaceflight for a wider, more diverse population,said James Hury, TRISH Chief Innovation Officer and Deputy Director. BioIntelliSense (Booth #5025) and TRISH (Space Health Pavilion #2636) will be showcasing the BioButton wearable device and clinical intelligence solution at the premier HLTH 2022 conference November 13 – 16 in Las Vegas, NV. ABOUT BIOINTELLISENSE BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for remote patient monitoring (RPM). Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The medical-grade BioButton® wearable device makes remote monitoring and early detection simple. Through the platform’s advanced analytics, clinicians have access to high-resolution patient trending and reporting to enable medical grade remote care from in-hospital to home. ABOUT TRANSLATIONAL RESEARCH INSTITUTE for SPACE HEALTH (TRISH) Led by Baylor College of Medicine’s Center for Space Medicine, TRISH is a consortium that includes partners Caltech and MIT. NASA recently awarded the Institute a six-year extension to further its work by delivering disruptive solutions to mitigate biomedical risks for human exploration while advancing terrestrial health technologies.

Read More

Digital Healthcare

MedX Health and Health Partners Announce Agreement to Launch MedX’s Teledermatology Screening Platform

MedX Health Corp | March 03, 2022

MedX Health Corp.("MedX" or the "Company"), a global leader in teledermatology, is pleased to announce a Memorandum of Understanding (“MOU”) and the launch of a new commercialization pilot project with Health Partners (OH) Limited, a well-respected, privately-owned corporate health, treatment and primary care services company in the United Kingdom. Serving a broad client base comprising corporates, government agencies, insurers, health trusts, pension funds and individuals, Health Partners (“HP”) employs 700+ people with telehealth, mobile and on-site operations across the UK and the Republic of Ireland. The pilot will span three to six months and involve an estimated 600 patients across two of HP’s sites. Upon the successful completion of the pilot, the MedX DermSecure® Screening Platform will be made available to Health Partners' two million-plus patients. The agreement is the latest initiative in MedX’s global commercialization strategy and follows pilots recently launched across the Europe and Middle East region. "Health Partners’ Clinical Team constantly strives to identify leading technological innovations that offer the highest level of support to our two million-plus patients. MedX's leading skin assessment technology allows dermatologists to not only make more accurate diagnoses of pigmented lesions and moles, but to do that remotely and quickly. We are very proud to be partnering with MedX Health to bring this innovative and life-changing service to our clients.” Health Partners Managing Director Andrew Noble In addition to expanding its DermSecure® Screening Platform network globally, MedX has focused on building a presence in multiple market verticals such as pharmacies, medical clinics, building hubs, medical scanning clinics, mobile and remote medical practices, as well as esthetics and skincare clinics. The partnership with Health Partners represents MedX’s expansion into a new vertical; occupational health and wellbeing services. MedX Managing Director, Europe, Middle East and Africa (EMEA), Naman Demaghlatrous, added, "MedX is pleased to have established a presence in the strategic occupational health vertical. Health Partners brings our technology to a population of more than two million workers across the United Kingdom, thus expanding our footprint in the EMEA region considerably. We continue to execute on our strategy to identify strategic partnerships in the region that will allow us to grow our business and save lives simultaneously.” Health Partners will pilot MedX’s high-definition image-capture technology, SIAscopy®, and its secure, cloud-based patient management system, DermSecure®, which transmits and stores patient data throughout the assessment process. MedX's SIAscopy® is the only technology available that captures five high-resolution images of suspicious moles, lesions and skin conditions, including four spectrophotometric images taken 2mm below the skin's surface. This technology provides detailed patient scans, which a certified dermatologist can virtually assess within 72 hours. "We are honoured to be working with Health Partners on this most important initiative. According to Health & Safety Executive-commissioned research, there are more than 3000 cases of skin cancer annually in the construction industryalone. We are delighted to be entering the occupational health services market with a leader in the industry," stated Mike Druhan, MedX President, Dermatology Services. About Health Partners (OH) Ltd. Health Partners, headquartered in Uckfield, East Sussex, United Kingdom, is a leading health and wellbeing company, providing a full range of corporate health, treatment and primary care services to corporates, government, insurers, health trusts, pension funds and families. We combine expert advice and clinical services with smart systems to deliver impact-driven health programmes, tailored to improve people’s wellbeing and performance. Health Partners is founded on patient privacy and holds a significant number of accreditations, certifications and memberships, including ISO27001, CQC, SEQOHS and ISO9001. Health Partners offers its services across the United Kingdom and the Republic of Ireland, reaching two million plus people in organisations across several industries. About MedX Health Corp. MedX, headquartered in Ontario, Canada, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also imbedded in its products SIAMETRICS®, SIMSYS®, and MoleMate®, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS®, SIMSYS®, and MoleMate® include hand-held devices that use patented technology utilizing light and its remittance to view suspicious moles and lesions up to 2mm beneath in a pain-free, non-invasive manner. Its patented software then creates real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are cleared by Health Canada, the U.S. Food and Drug Administration, the Therapeutic Goods Administration and Conformité Européenne for use in Canada, the U.S., Australia, New Zealand, the European Union, Brazil and Turkey.

Read More

Digital Healthcare

Cognizant Collaborates with Microsoft to Offer New Virtual Healthcare Solution for Remote Patient Monitoring and Improved Care

Cognizant | March 02, 2022

Cognizant today announced it is collaboratingwith Microsoft to delivera new digital health solution to enhance remote patient monitoring for improved medical care. Cognizant's new solution, leveraging components of the Microsoft Cloud for Healthcare, is the first of several planned offerings that combine remote patient monitoring and virtual health, utilizing products like smart watches, blood pressure monitors, and glucose meters to collect and communicate patient health data to providers. Built-in analytics allow providers to cross-reference historical health information to gain patient insights and potentially identify early warning signs of chronic conditions so preventative measures can be taken. Additionally, the solution's remote capabilities enable telehealth visits, which continue to be a valuable option to mitigate barriers of care for patients with accessibility constraints, as well as implement time-sensitive interventions and improve personalized care. With chronic diseases expected to account for 70% of global deaths by 2030, advancements in digital integration are quickly becoming recognized as an optimal approach to preventing, managing, and treating disease.* As an early Microsoft Cloud for Healthcare partner, Cognizant has designed a solution that leverages Microsoft Azure services including FHIR, API Services, and Teams integration to improve scalability and reliability. This digital healthcare endeavor is backed by Cognizant's dedicated Microsoft Business Group, bringing together Cognizant's digital modernization expertise with Microsoft's focus on building Industry Clouds to deliver a commercially available, comprehensive, healthcare solution. This new offering is the first in a series of digital healthcare solutions from Cognizant as the company accelerates its client offerings aimed at implementing advanced healthcare technology to increase patient engagement, enhance personalized care, provide remote patient monitoring, and facilitate improved patient outcomes. Future offerings will build upon existing solution capabilities to help clients expedite implementation. "The bridging of technology and healthcare is creating new opportunities to improve how providers monitor the health of their patients and engage with them for time-sensitive interventions. Utilizing data analytics, secure cloud technology and interoperability products, our collaboration with Microsoft offers a unique, scalable solution that aims to connect providers and patients, and enhances the quality, timeliness, and personalization of healthcare." Surya Gummadi, Head of Cognizant Healthcare "Cognizant's new virtual healthcare solution utilizes differentiated capabilities, built on the secure and compliant Microsoft Cloud, that make it easy for people to collect and share health data using their own devices, while ensuring that providers have the data and insights they need to diagnose and treat patients," saidTom McGuinness, Corporate Vice President, Global Healthcare and Life Sciences, Microsoft. "We look forward to combining our technologies and collective expertise to deliver additional solutions that offer high quality healthcare and enable patient well-being." About Cognizant Cognizantengineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life.

Read More

Events